CSCI
Price
$3.42
Change
+$0.01 (+0.29%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
10.84M
JANX
Price
$24.45
Change
+$0.39 (+1.62%)
Updated
Jul 3 closing price
Capitalization
1.42B
39 days until earnings call
Interact to see
Advertisement

CSCI vs JANX

Header iconCSCI vs JANX Comparison
Open Charts CSCI vs JANXBanner chart's image
COSCIENS Biopharma
Price$3.42
Change+$0.01 (+0.29%)
VolumeN/A
Capitalization10.84M
Janux Therapeutics
Price$24.45
Change+$0.39 (+1.62%)
Volume$302.43K
Capitalization1.42B
CSCI vs JANX Comparison Chart in %
Loading...
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSCI vs. JANX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSCI is a Hold and JANX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (CSCI: $3.41 vs. JANX: $24.45)
Brand notoriety: CSCI and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSCI: 84% vs. JANX: 33%
Market capitalization -- CSCI: $10.84M vs. JANX: $1.42B
CSCI [@Biotechnology] is valued at $10.84M. JANX’s [@Biotechnology] market capitalization is $1.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSCI’s FA Score shows that 0 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • CSCI’s FA Score: 0 green, 5 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, JANX is a better buy in the long-term than CSCI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSCI’s TA Score shows that 3 TA indicator(s) are bullish while JANX’s TA Score has 6 bullish TA indicator(s).

  • CSCI’s TA Score: 3 bullish, 5 bearish.
  • JANX’s TA Score: 6 bullish, 1 bearish.
According to our system of comparison, JANX is a better buy in the short-term than CSCI.

Price Growth

CSCI (@Biotechnology) experienced а +1.19% price change this week, while JANX (@Biotechnology) price change was +3.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CSCI is expected to report earnings on Apr 09, 2025.

JANX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($1.42B) has a higher market cap than CSCI($10.8M). CSCI YTD gains are higher at: 23.105 vs. JANX (-54.333). CSCI has higher annual earnings (EBITDA): -15.36M vs. JANX (-111.54M). JANX has more cash in the bank: 1.01B vs. CSCI (13.8M). CSCI has less debt than JANX: CSCI (2.23M) vs JANX (22.6M). JANX (9.34M) and CSCI (9.03M) have equivalent revenues.
CSCIJANXCSCI / JANX
Capitalization10.8M1.42B1%
EBITDA-15.36M-111.54M14%
Gain YTD23.105-54.333-43%
P/E RatioN/AN/A-
Revenue9.03M9.34M97%
Total Cash13.8M1.01B1%
Total Debt2.23M22.6M10%
FUNDAMENTALS RATINGS
CSCI: Fundamental Ratings
CSCI
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSCIJANX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBSPX48.29N/A
N/A
Franklin S&P 500 Index A
CCAFX37.69N/A
N/A
Calvert Mid-Cap A
LADCX9.62N/A
N/A
Lord Abbett Developing Growth C
NPNCX48.40N/A
N/A
Neuberger Berman Large Cap Value C
WAUSX15.05N/A
N/A
Wasatch US Select Investor

CSCI and

Correlation & Price change

A.I.dvisor tells us that CSCI and SLDB have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSCI and SLDB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSCI
1D Price
Change %
CSCI100%
N/A
SLDB - CSCI
30%
Poorly correlated
+3.29%
SNGX - CSCI
30%
Poorly correlated
-4.76%
JANX - CSCI
29%
Poorly correlated
+5.30%
ARDX - CSCI
28%
Poorly correlated
+1.91%
FATE - CSCI
27%
Poorly correlated
N/A
More

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with SKYE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then SKYE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+5.30%
SKYE - JANX
41%
Loosely correlated
+23.26%
CRNX - JANX
39%
Loosely correlated
+1.22%
IDYA - JANX
37%
Loosely correlated
+0.82%
APGE - JANX
36%
Loosely correlated
+7.08%
ORMP - JANX
36%
Loosely correlated
+0.93%
More